Device
Single vision spectacle lens
Single vision spectacle lens is a medical device with 7 clinical trials. Currently 6 active trials ongoing. Historical success rate of 100.0%.
Total Trials
7
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
6(86%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
6
86%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution6 total trials
N/ANon-phased studies
6(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
6
trials recruiting
Total Trials
7
all time
Status Distribution
Active(6)
Completed(1)
Detailed Status
Active, not recruiting3
Recruiting3
Completed1
Development Timeline
Analytics
Development Status
Total Trials
7
Active
6
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A6 (100.0%)
Trials by Status
active_not_recruiting343%
completed114%
recruiting343%
Recent Activity
6 active trials
Showing 5 of 7
active_not_recruitingnot_applicable
The Evaluation of Safety and Myopia Progression Control Using Novel Spectacle Lens
NCT05886348
active_not_recruitingnot_applicable
The P.A.U.S.E.® Spectacle Study
NCT06577948
completednot_applicable
Myopia Control With a Innovative Spectacle Lens
NCT05174780
recruitingnot_applicable
DG1 Spectacle Lens for Myopia Progression Control in Children
NCT06781931
recruitingnot_applicable
The A.R.R.E.S.T.® Spectacle Film Study
NCT06692699
Clinical Trials (7)
Showing 7 of 7 trials
NCT05886348Not Applicable
The Evaluation of Safety and Myopia Progression Control Using Novel Spectacle Lens
NCT06577948Not Applicable
The P.A.U.S.E.® Spectacle Study
NCT05174780Not Applicable
Myopia Control With a Innovative Spectacle Lens
NCT06781931Not Applicable
DG1 Spectacle Lens for Myopia Progression Control in Children
NCT06692699Not Applicable
The A.R.R.E.S.T.® Spectacle Film Study
NCT06137560Not Applicable
Spectacle Films Utilising S.T.O.P.® Technology for Slowing Down Myopia Progression in Children
NCT05943912
Myopia Control Effect of DIMS Spectacle Lenses in Czech Children and Young Adults
All 7 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 7